1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

What would the pharmaceutical industy look like under a Clinton presidency?

Discussion in 'The Politics of Healthcare' started by mbryan, Feb 29, 2016 at 11:56 AM.

  1. mbryan

    mbryan Administrator
    Staff Member

    Jul 19, 2015
    Likes Received:
    What would a President Clinton do to pharma?

  2. anonymous

    anonymous Guest

    It would look about like it does now. Maybe there would be some "fine tuning" that might help and might hurt, but that would be about it.
  3. anonymous

    anonymous Guest

    It would all depend on how much PhRMA donates to the Clinton Foundation.